MARY BARKALOW: Open Payments
NPI 1700864485 · WEST SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,401 in 143 payments from 12 companies in 2025. Trend: 2023 $3,565 · 2024 $3,244 · 2025 $3,401
Food & beverage: $3,256Education: $145
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 30 | $525 |
| ABBVIE INC. | 16 | $452 |
| Neurocrine BioSciences, Inc. | 14 | $432 |
| E.R. Squibb & Sons, L.L.C. | 15 | $396 |
| Teva Pharmaceuticals USA, Inc. | 10 | $309 |
| Otsuka America Pharmaceutical, Inc. | 8 | $299 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $273 |
| Janssen Pharmaceuticals, Inc | 14 | $242 |
| Alkermes, Inc. | 7 | $213 |
| Indivior Inc. | 8 | $167 |
Products named: FANAPT, VRAYLAR, INGREZZA, COBENFY, AUSTEDO XR, CAPLYTA, ABILIFY ASIMTUFII, SUBLOCADE.
Industry payments across MA — which companies pay providers there.
